Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
CESC | rs2096188 | chr9:115566594 | A/G | 4.42E-9 | 298 | 8 | 19.43 | 23.12 | KM Plot |
CESC | rs2100238 | chr3:161058055 | T/A | 2.55E-5 | 299 | 25.82 | 20.63 | 19.05 | KM Plot |
CESC | rs2114833 | chr10:88225388 | G/C | 1.6E-14 | 297 | 3.33 | 24.6 | 21.17 | KM Plot |
CESC | rs2153839 | chr9:115559659 | A/G | 3.03E-5 | 288 | 8.43 | 24.63 | 23.12 | KM Plot |
CESC | rs2236403 | chr14:90736325 | C/T | 2.26E-5 | 299 | 20.63 | 21.4 | 24.33 | KM Plot |
CESC | rs2237905 | chr11:2976584 | T/C | 4.96E-5 | 297 | 21.27 | 21.15 | 23.32 | KM Plot |
CESC | rs2242626 | chr14:77324937 | A/G | 8.37E-5 | 299 | 21.33 | 21.97 | 7.67 | KM Plot |
CESC | rs2271293 | chr16:67902070 | A/G | 5.25E-5 | 299 | 18.17 | 25.13 | 21.2 | KM Plot |
CESC | rs2272634 | chr8:144400089 | C/T | 2.43E-5 | 293 | 27.2 | 21.1 | 17.32 | KM Plot |
CESC | rs2273549 | chr11:33079580 | A/G | 5.0E-6 | 299 | 21.4 | 26.77 | 1.73 | KM Plot |
CESC | rs2273551 | chr11:33097691 | C/T | 0 | 297 | 21.97 | 20.13 | 0.5 | KM Plot |
CESC | rs2273553 | chr11:33097877 | A/G | 4.33E-5 | 299 | 1.73 | 21.08 | 21.85 | KM Plot |
CESC | rs2275722 | chr10:135077020 | C/T | 1.92E-10 | 295 | 11.6 | 21.85 | 21.23 | KM Plot |
CESC | rs2275725 | chr10:135089035 | A/G | 4.59E-10 | 296 | 7.47 | 21.73 | 21.4 | KM Plot |
CESC | rs2292316 | chr16:67861134 | C/G | 3.67E-5 | 299 | 16.92 | 25.82 | 21.07 | KM Plot |